Networking +
Policy +
Member
Career
Choose
News + Blog
Get weekly updates from Colorado’s leading source for life sciences news and information. Read More
You searched for "what is true transparency". Here are the results:
Drug Price Caps Are the Wrong Solution for Patients
Patients say Upper Payment Limits (UPLs) won’t make their medicines more affordable. Colorado’s Prescription Drug Affordability Board (PDAB) hasn’t listened. Colorado’s PDAB was created to review the impact of prescription drug costs on Coloradans. The PDAB may address affordability by s... Read More
2024 Rocky Mountain Life Sciences Investor and Partnering Conference Presenting Companies
Colorado BioScience Association members drive global health innovations, products, and services that improve and save lives. Their dedication and passion inspires us. Read More
Weekly Policy Blog: PDAB Releases Stakeholder Engagement Guide on Affordability Review Process
As the Colorado Prescription Drug Affordability Board (PDAB) begins affordability reviews of the five prescription drugs selected earlier this month, it is reaching out to stakeholders to request their engagement in the affordability review process via their Stakeholder Engagement Guide. Speci... Read More
$5.2 Million Advanced Industries Awards in Fall 2019 Will Fuel 24 Colorado Start-ups
A Colorado company with the transformative technology behind a revolutionary prosthetic socket design that provides easier application and release was among 24 Colorado start-ups approved for funding as part of the Colorado Office of Economic Development and International Trade (OEDIT)’s Advanced In... Read More
Weekly Policy Update: Primary Elections, Congratulating Sen. Gardner, and Drug Pricing
2018 COLORADO PRIMARY ELECTION With the anticipated Colorado Primary Election this week, we learned the long-awaited results of who would be our top two democratic and republican candidates for Governor. This was a crowded race with the Democratic party candidate Jared Polis and the Republican Party... Read More
Weekly Policy Update: Drug Pricing News
This week HHS Secretary Alex Azar appeared in front of the Senate Health, Education, Labor and Pensions Committee for a hearing on drug pricing. Secretary Azar’s prepared testimony in large part summarized President Trump’s blue print. For more information on the blueprint click here and to view the... Read More
Weekly Policy Update: BIO International Convention and Voter Registration
This week CBSA President and CEO April Giles and Vice President Jennifer Jones returned from the 2018 BIO International Convention in Boston, Massachusetts. This annual trip is a great opportunity to meet with CBSA member companies, industry partners, and other bioscience supporters. The convention... Read More
Coming Together as a Community
Collaborating on True Transparency to Benefit Patients Our state’s bioscience innovators work to create wearable devices to help make us healthier, develop drugs that could save a loved one from cancer, and identify disease-causing viruses and bacteria in food and water before they can make people s... Read More
Prescription Drugs: Just the Facts
As the Colorado State Legislature considers House Bill 18-1260, Drug Price Transparency, a lot of claims and opinions are circulating in our state about the drivers of health care costs. Prescription drugmakers are a familiar target for those looking to place blame on rising out-of-pocket costs to p... Read More